Vaxcyte · 1 month ago
Vice President, US Trade & Distribution
United States
Full-time
Remote
Director/Executive
$315K/yr - $368K/yr
15+ years expVaxcyte is a clinical-stage vaccine innovation company focused on developing high-fidelity vaccines to combat bacterial diseases. The Vice President of US Trade & Distribution will lead the strategy for the commercial launch of Vaxcyte’s adult pneumococcal vaccine, ensuring effective distribution and access in retail pharmacy and Integrated Delivery Network channels.
BiopharmaBiotechnologyHealth Care
Responsibilities
Develop and own the enterprise-wide channel, trade, and distribution strategy for the initial adult vaccine launch, ensuring alignment with brand, market access, and supply chain priorities
Design integrated models that balance clinical needs, commercial access, supply chain efficiency, and gross-to-net cost considerations
Anticipate and respond to U.S. market and regulatory trends that impact retail and IDN distribution, preparing for future pediatric launches
Oversee end-to-end planning and execution for the forward supply chain, including model selection, proposal development, negotiations, and partner review, selection and contracting
Lead all logistical operations to ensure readiness, including EDI, cold chain management, inventory placement, and order-to-cash systems, ensuring they are fully developed and functional
Ensure Day One launch readiness by meeting all regulatory requirements, securing product availability at targeted retail and IDN accounts, and implementing robust safety stock and contingency plans
Establish and manage the pharmacy and distribution networks for Vaxcyte
Build, negotiate and manage the contractual agreements and strong working relationships with channel, trade, and distribution and pharmacy partners
Select, onboard, and oversee strategic partners, including RFP requirements and process management
Build and maintain effective relationships with distributors, retail chains and large IDNs to optimize distribution performance and patient access
Design, build negotiate and manage Trade Policies, Authorized Distribution Agreements (ADA), and Distribution Service Agreements (DSA)
Manage all aspects of ongoing distribution account operations, including performance reviews, launch of new programs or service offerings, and comprehensive customer relationship oversight
Build the Trade Operations Team who will manage DSA performance, inventory levels, and Service Level fill rates, distribution data, and the underlying technology infrastructure
Establish systems and SOPs to ensure compliance with all relevant federal and state regulations (e.g., FDA, DSCSA, Anti-Kickback Statute), focusing on operational integrity and legal adherence
Implement data-driven processes to enhance supply chain transparency and enable informed operational decisions by leveraging both internal and external data sets (e.g., 852, 867, DDD)
Monitor and manage launch operational KPIs such as inventory levels, fulfillment rates, customer experience, and distribution costs, with a focus on process optimization
Develop and oversee risk mitigation and inventory management strategies to maintain continuous product distribution regardless of disruptions
Drive ongoing process improvement by utilizing analytics and gathering feedback, with targeted attention on retail and IDN (Integrated Delivery Network) segments
Serve as the primary Trade representative on commercial and launch excellence teams, ensuring alignment and integration across functions
Support gross-to-net planning through deep channel economics expertise
Qualification
Required
BA/BS degree in a scientific discipline, business, or marketing required
MBA or other advanced degree highly desired
Minimum of 15 years of industry related experience preferred with 7+ years of progressive experience in U.S. pharmaceutical or biotech trade, commercial operations, distribution, contracting, or market access, including leadership roles in product launches
Demonstrated experience launching U.S. vaccines and/or specialty biologics (highly preferred)
In-depth knowledge of the U.S. commercial and government healthcare and reimbursement environment, including distribution channels, retail pharmacy channels, Integrated Delivery Networks (IDNs), contract negotiation, gross-to-net planning
Extensive regulatory expertise and experience with major commercial and government payer programs (State Medicaid, Medicare, VFC, Section 317)
Experience and understanding of point-of-sale programs for retail pharmacy or equivalent environments
Ability to travel 20-40% of the time for various individual & national customer meetings
Ability to create and execute strategic vision
Outstanding verbal, written, and interpersonal communication skills
Excellence in project management and driving operational rigor
Leadership of cross-functional teams with strong collaborative skills
Data-driven analytical decision-making
Thorough regulatory and compliance acumen
Skilled in contracting and negotiation with retail and IDN customers
Innovative approach to implementing digital and logistics solutions for retail/IDN account management
Capacity to rapidly assimilate information and prioritize/manage multiple initiatives
Proven ability to influence at executive level and work effectively across organizational boundaries
Benefits
Comprehensive benefits
An equity component
Company
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
201-500 employees
H1B Sponsorship
Vaxcyte has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (7)
2023 (5)
2022 (7)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$3.85BKey Investors
CARB-XTPG GrowthAbingworth
2024-09-04Post Ipo Equity· $1.5B
2024-01-30Post Ipo Equity· $862.5M
2023-04-19Post Ipo Equity· $500M
Leadership Team
Andrew Guggenhime
President & Chief Financial Officer
Jeff Fairman
Founder and Vice President, Research
Recent News
2025-12-09
Company data provided by crunchbase